Bellevue Group AG

Q4 2023 13F-HR Holdings

Location
Kuesnacht, V8
Holdings as of
12/31/2023
Date filed
2/14/2024
Form type
13F-HR
Num holdings
161
Total value ($000)
$6,537,470
Net value change ($000)
+330,558 (5.3%)
New positions
25
Sold out positions
18
Turnover %
2.1%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 11/14/2023 Next filing: 5/15/2024 SEC filing

Snapshot: Change Analysis

Compared to Q3 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IMCR 65,654 6374.2%
ARVN 61,479 147.3%
Intra-Cellular Therapies, Inc. 54,478 33.0%
MGNX 50,068 109.6%
DXCM 49,513 77.4%
BHVN 46,010 NEW
BSX 43,569 31.2%
CLDX 43,542 83.3%
GEHC 40,529 4762.5%
ISRG 38,389 15.8%
Top Reduces (Value $000, Stocks/ETFs)
ARGX -117,460 -26.2%
UNH -57,451 -44.1%
VRTX -49,061 -14.1%
HUM -36,734 -44.4%
JAZZ -34,460 -100.0%
IQV -28,629 -93.7%
Shockwave Medical, Inc. -26,843 -53.0%
ELV -24,885 -32.9%
EVH -21,616 -21.6%
MOH -18,899 -36.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type